Advertisement
Advertisement
IMMP
Immutep Limited - ADR
0.37
USDSponsored
+0.01
+2.22%
Mar 25, 16:00 UTC -4
Closed
After-Market
0.37
0.00
-0.27%
IMMP Earnings Reports
Positive Surprise Ratio
IMMP beat 6 of 10 last estimates.
60%
Next Report
Date of Next Report
Jul 29, 2026
Estimate for Q4 26 (Revenue/ EPS)
$2.53M
/-$0.02
Implied change from Q2 26 (Revenue/ EPS)
-67.28%
/-33.33%
Implied change from Q4 25 (Revenue/ EPS)
-17.16%
/--
Immutep Limited - ADR earnings per share and revenue
On Jan 29, 2026, IMMP reported earnings of -0.03 USD per share (EPS) for Q2 26, missing the estimate of -0.02 USD, resulting in a -9.89% surprise. Revenue reached 7.74 million, compared to an expected 17.52 million, with a -55.86% difference. The market reacted with a -2.94% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 2 analysts forecast an EPS of -0.02 USD, with revenue projected to reach 2.53 million USD, implying an decrease of -33.33% EPS, and decrease of -67.28% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Precigen, Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.01
Surprise
+88.24%
Absci Corporation Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.23
Surprise
-16.04%
Candel Therapeutics, Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.25
Actual
-$0.54
Surprise
-115.31%
LENZ Therapeutics, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.99
Actual
-$1.15
Surprise
-17.10%
Fennec Pharmaceuticals Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
$0.03
Actual
-$0.11
Surprise
-408.12%
Equillium, Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.06
Actual
-$0.04
Surprise
+35.28%
MaxCyte, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.06
Surprise
+26.47%
Celcuity Inc. Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$1.06
Actual
-$0.97
Surprise
+8.72%
Dyadic International, Inc.
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.04
Actual
-$0.06
Surprise
-30.72%
TELA Bio, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.18
Actual
-$0.16
Surprise
+14.12%
FAQ
What were Immutep Limited - ADR's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Immutep Limited - ADR reported EPS of -$0.03, missing estimates by -9.89%, and revenue of $7.74M, -55.86% below expectations.
How did the market react to Immutep Limited - ADR's Q2 2026 earnings?
The stock price moved down -2.94%, changed from $3.06 before the earnings release to $2.97 the day after.
When is Immutep Limited - ADR expected to report next?
The next earning report is scheduled for Jul 29, 2026.
What are the forecasts for Immutep Limited - ADR's next earnings report?
Based on 2
analysts, Immutep Limited - ADR is expected to report EPS of -$0.02 and revenue of $2.53M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement